Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.
Clinical trial NCT00191620 · COMPLETED
Trial details
- NCT number
- NCT00191620
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.